Catalyst Biosciences Stock Price (NASDAQ:CBIO)

Add to My Stocks
$12.44 $0.32 (2.64%) CBIO stock closing price Jul 13, 2018 (Closing)
Prev Close* : $12.12
Market Cap:
$148.47M
Day Low: $11.83
52 Week Low: $3.11
Open: $12.15
Volume: -
Day High: $12.5
52 Week High: $37.00
Dividend:
0.00

Latest Stock Market News

Latest Articles

Catalyst Biosciences News - From Partners

4 Stocks to Bet on New Analyst Coverage   by Zacks on Mar 08, 2018

CBIO Stockcharts

View CBIO PE ratio, PS ratio stocks charts and compare with peers.
CBIO Chart
Note: Compare Catalyst Biosciences stock price history with the index and industry peers.

Catalyst Biosciences Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
143.37
PB ratio (
price to book ratio
)
2.25

Catalyst Biosciences Returns

ROE
(return on equity)
-46%

Catalyst Biosciences Financial Ratios

Asset Turnover
0
Receivables Turnover
9.05
Debt to Equity
0
Dividend Yield
0%

CBIO Industry Peers

Company Price Change (%)
Nabriva Therapeutics (NBRV)3.570.04 (1.13%)
Bellerophon Therapeutics (BLPH)2.880.16 (5.88%)
Nektar Therapeutics (NKTR)47.790.12 (0.25%)
Progenics Pharma (PGNX)8.320.05 (0.6%)
Sucampo Pharma (SCMP)180 (0%)
Abeona Therapeutics (ABEO)14.750.65 (4.22%)
Synergy Pharma (SGYP)1.90.05 (2.56%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.140.21 (7.17%)
Momenta Pharma (MNTA)281.65 (6.26%)
Verastem (VSTM)8.50.44 (5.46%)
Pluristem Therapeutics (PSTI)1.30.05 (4%)
Uniquire (QURE)39.451.46 (3.84%)
Alder BioPharma (ALDR)19.250.7 (3.77%)
MediciNova (MNOV)8.810.27 (3.16%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 14, 2018
CompanyPriceChange (%)
Vericel Corp (VCEL)9.11.05 (10.34%)
Sorrento Therapeutics (SRNE)7.10.4 (5.33%)
Geron (GERN)3.620.19 (4.99%)
Dicerna Pharma (DRNA)12.50.64 (4.87%)
Amicus Therapeutics (FOLD)15.750.79 (4.78%)
Idera Pharma (IDRA)1.010.05 (4.72%)
MannKind (MNKD)1.70.08 (4.49%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 14, 2018

Catalyst Biosciences Inc Stock News - Partner Headlines

Catalyst Biosciences Financial Statements

income statement20172016201520142013
Net Sales or Revenues1.01M-1.75M-3.62M
Net Income-21.56M-16.94M-14.76M-32.62M-46.7M
Total Operating Expense22.83M20.81M15.54M29.98M50.84M
View Catalyst Biosciences income statement
balance sheet20172016201520142013
Total Assets39.51M38.09M69.52M111.99M145.87M
Total Liabilities8.73M22.01M38.09M2.91M11.26M
Shareholders Equity30.77M16.07M31.42M109.08M134.61M
View Catalyst Biosciences balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities---6.25M-6.36M2.73M
Net Cash from (used by) Operating Activities-19.94M-18.47M-19.11M-34.48M-40.61M
Increase (Decrease) in Prop Plant And Equipment-0.02M2.09M-0.27M-1.07M
View Catalyst Biosciences cash flow statement

Catalyst Biosciences Stock Message Board

An investor needs to spend $12.44 to buy CBIO stock, as the closing Catalyst Biosciences stock price is $12.44. Stock price or share price can be used to find the total market value of a company. Catalyst Biosciences market cap stands at $148.47M as of Jul 13, 2018. Catalyst Biosciences valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Catalyst Biosciences stock price and Catalyst Biosciences share price mean the same thing. The volume number in Catalyst Biosciences stock quote data shows the number of shares traded. For Ex: 316,727 Catalyst Biosciences shares were traded as of last trading day, as seen from Catalyst Biosciences stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Catalyst Biosciences stock dividend was 0.00 during the last quarter. Catalyst Biosciences stock price history, gives the entire historical data for CBIO stock.